Gene silencing through RNA interference: Considerations on the mechanism and design of effectors systems;Silenciamiento de genes mediante RNA interferencia: Consideraciones sobre el mecanismo y diseño de los sistemas efectores

Archivos Venezolanos de Farmacologia y Terapeutica

Volumn 27, Issue 1, 2008, Pages 22-26

  Correa De Adjounian, Maria Fernanda ^a,b   Adjounian, Haroution ^a,b,c   Adjounian, Sarkis Horacio ^a,b  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b Escuela Luís Razetti

^c HÔPITAL DU BOCAGE   (France)

Author keywords

Effectors systems; RNA interference; RNAi mechanism

Indexed keywords

SMALL INTERFERING RNA;

CONFERENCE PAPER; GENE EXPRESSION; GENE SILENCING; NONHUMAN; RNA INTERFERENCE; RNA SEQUENCE; RNA STRUCTURE; RNA TRANSPORT;

EID: 55349125360     PISSN: 07980264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Aboul-Fadl T. Antisense oligonucleotides: the state of the art. Curr Med Chem. 2005;12 (19):2193-214.
2. Tafech A, Bassett T, Sparanese D, Lee CH. Destroying RNA as a therapeutic approach. Curr Med Chem. 2006;13 (8):863-81.
3. Amantana A, Iversen PL. Pharmacokinetics and biodistribution of phosphorodiamidate morpholino antisense oligomers. Curr Opin Pharmacol. 2005;5 (5):550-5.
4. Dykxhoorn DM, Lieberman J. The silent revolution: RNA interference as basic biology, research tool, and therapeutic. Annu Rev Med. 2005;56: 401-23.
5. Hudson DF, Morrison C, Ruchaud S, Earnshaw WC. Reverse genetics of essential genes in tissue-culture cells: 'dead cells talking'. Trends Cell Biol. 2002;12 (6):281.
6. Lee JF, Stovall GM, Ellington AD. Aptamer therapeutics advance. Curr Opin Chem Biol. 2006;10(3):282-9.
7. Sen GL, Blau HM. A brief history of RNAi: the silence of the genes. FASEB J. 2006; 20 (9):1293-9.
8. Napoli, C., Lemieux C, Jorgensen, R. Introduction of a chimeric chalcone synthase gene into petunia result in reversible co-supresion of homologous genes in trans. Plant Cell 1991; 2:279-289
9. Dallas A, Vlassov AV. RNAi: a novel antisense technology and its therapeutic potential. Med Sci Monit. 2006;12 (4):RA67-74
10. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001 24;411 (6836):494-8.
11. Snove O Jr, Rossi JJ. Expressing short hairpin RNAs in vivo. Nat Methods. 2006; 3(9):689-95.
12. Morris KV, Rossi JJ. Lentivirus-mediated RNA interference therapy for human immunodeficiency virustype 1 infection. Hum Gene Ther. 2006;17 (5):479-86.
13. Bernstein E, Caudy AA, Hammond SM, Hannon GJ. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature. 2001;409 (6818):363-6
14. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE y Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391(6669):806-11
15. Couzin J. Nobel Prize in Physiology or Medicine. Method to silence genes earns loud praise. Science. 2006;314(5796):34.
16. Cullen BR. Enhancing and confirming the specificity of RNAi experiments. Nat Methods. 2006;3(9):677-81
17. Pei Y, Tuschl T. On the art of identifying effective and specific siRNAs. Nat Methods. 2006 ;3 (9):670-6
18. Putnam D y Doody A. RNA-interference effectors and their delivery. Crit Rev Ther Drug Carrier Syst. 2006;23 (2):137-64
19. Song E, Zhu P, Lee SK, Chowdhury D, Kussman S, Dykxhoorn DM, Feng Y,Palliser D, Weiner DB, Shankar P, Marasco WA, Lieberman J. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat Biotechnol. 2005; 23(6):709-17.
20. Li CX, Parker A, Menocal E, Xiang S, Borodyansky L, Fruehauf JH. Delivery of RNA interference. Cell Cycle. 2006;5(18):2103-9.
21. Wiznerowicz M, Szulc J, Trono D. Tuning silence: conditional systems for RNA interference. Nat Methods. 2006;3(9):682-8.